Urokinase 250,000 HS powder for solution for injection vials Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

urokinase 250,000 hs powder for solution for injection vials

imported (germany) - urokinase - powder for solution for injection - 250000unit

Urokinase HS 500,000unit powder for solution for injection vials Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

urokinase hs 500,000unit powder for solution for injection vials

imported (germany) - urokinase - powder for solution for injection - 500000unit

kinlytic- UROKINASE injection, powder, lyophilized, for solution Estats Units - anglès - NLM (National Library of Medicine)

kinlytic- urokinase injection, powder, lyophilized, for solution

imarx therapeutics, inc. - urokinase (unii: 83g67e21xi) (urokinase - unii:83g67e21xi) - injection, powder, lyophilized, for solution - 250000 [iu] in 5 ml - kinlytic™ is indicated in adults: - for the lysis of acute massive pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments. - for the lysis of pulmonary emboli accompanied by unstable hemodynamics, i.e., failure to maintain blood pressure without supportive measures. the diagnosis should be confirmed by objective means, such as pulmonary angiography or non-invasive procedures such as lung scanning. the use of kinlytic™ is contraindicated in patients with a history of hypersensitivity to the product (see warnings and adverse reactions ). because thrombolytic therapy increases the risk of bleeding, kinlytic™ is contraindicated in the situations listed below (see warnings ). - active internal bleeding - recent (e.g., within two months) cerebrovascular accident - recent (e.g., within two months) intracranial or intraspinal surgery - recent trauma including cardiopulmonary resuscitation - intracranial neoplasm, arteriovenous malformation, or aneurysm - known bleeding diatheses - seve

Actosolv 100000 IU inj./inf. sol. (pwdr.) i.arter./i.v. Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

actosolv 100000 iu inj./inf. sol. (pwdr.) i.arter./i.v.

eumedica pharmaceuticals gmbh - urokinase 100000 iu - powder for solution for injection/infusion - 100.000 iu - urokinase 100000 iu - urokinase

Actosolv 600000 IU inj./inf. sol. (pwdr.) i.arter./i.v. Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

actosolv 600000 iu inj./inf. sol. (pwdr.) i.arter./i.v.

eumedica pharmaceuticals gmbh - urokinase 600000 iu - powder for solution for injection/infusion - 600.000 iu - urokinase 600000 iu - urokinase

KINLYTIC OPEN-CATH POWDER FOR SOLUTION Canadà - anglès - Health Canada

kinlytic open-cath powder for solution

microbix biosystems inc - urokinase - powder for solution - 5000unit - urokinase 5000unit - thrombolytic agents

Syner-KINASE 250,000unit powder for solution for injection vials Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

syner-kinase 250,000unit powder for solution for injection vials

syner-med (pharmaceutical products) ltd - urokinase - powder for solution for injection - 250000unit

Syner-KINASE 500,000unit powder for solution for injection vials Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

syner-kinase 500,000unit powder for solution for injection vials

syner-med (pharmaceutical products) ltd - urokinase - powder for solution for injection - 500000unit

Ukidan Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

ukidan

douglas pharmaceuticals limited - urokinase 1e+006 [iu] (ex italy) - powder for injection - 1e+006 iu - active: urokinase 1e+006 [iu] (ex italy) excipient: aprotinin mannitol sodium chloride water for injection

Syner-KINASE 100,000unit powder for solution for injection vials Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

syner-kinase 100,000unit powder for solution for injection vials

syner-med (pharmaceutical products) ltd - urokinase - powder for solution for injection - 100000unit